As Targeted Therapies Evolve, Challenges Remain
نویسندگان
چکیده
منابع مشابه
Pediatric MLBL: challenges remain.
In this issue of Blood, Gerrard et al report the outcome and histologic classification of children and adolescents with mediastinal large B-cell lymphoma (MLBL), and highlight the need for new treatment strategies.
متن کاملTargeted Therapies in Breast Cancer: New Approaches and Old Challenges.
proaches interacting with growth factor signaling pathways that lead to estrogen receptor activation. Currently, we are experiencing relevant progress in endocrine therapy through approaches interacting with these signaling pathways, and several compounds will become available for clinical use within the next years. However, despite the fact that several compounds which target mTOR, PI3K, or CD...
متن کاملCommentary: Tackling the Challenges of Developing Targeted Therapies for Cancer
Disclosures: Richard L. Schilsky: None; Jeff Allen: None; Joshua Benner: None; Ellen Sigal: None; Mark McClellan: None. The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the authors or independent peer review...
متن کاملClinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer
Lung cancer is difficult to treat with a poor prognosis and a five year survival of 15%. Current molecularly targeted therapies are initially effective in non-small cell lung cancer (NSCLC) patients; however, they are plagued with difficulties including induced resistance and small therapeutically responsive populations. This mini review describes the mechanism of resistance to several molecula...
متن کاملMajor Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
Glioblastoma (GBM) is considered one of the most malignant, genetically heterogeneous, and therapy-resistant solid tumor. Therapeutic options are limited in GBM and involve surgical resection followed by chemotherapy and/or radiotherapy. Adjuvant therapies, including antiangiogenic treatments (AATs) targeting the VEGF-VEGFR pathway, have witnessed enhanced infiltration of bone marrow-derived my...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2004
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/96.5.351